Development and validation of the Crohnʼs disease perceived work disability questionnaire
Authors:
- Mercedes VergaraMVMercedes Vergara
- Antonia MontserratAMAntonia Montserrat
- Francesc CasellasFCFrancesc Casellas
- Olga GallardoOGOlga Gallardo
- David SuarezDSDavid Suarez
- Jaume MotosJMJaume Motos
- Albert VilloriaAVAlbert Villoria
- Mireia MiquelMMMireia Miquel
- Eva Martinez-BauerEMEva Martinez-Bauer
- Xavier CalvetXCXavier Calvet
- 1 November 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 17 (11) , 2350-2357
Abstract
No validated instruments have been developed to measure work disability in Crohn's disease (CD). The aim of our study was to develop and validate a CD perceived work disability questionnaire (CPWDQ). Development phase: an initial questionnaire containing 52 items was obtained from patients' interviews plus additional sources; it was completed by 106 patients and the 16 most significant items were selected using a psychometric method in order to create the CPWDQ. Validation phase: The validation assessed the questionnaire's convergent validity, discriminant validity, test-retest reproducibility, and internal consistency in 108 patients. Spearman rank correlation, t-test, intraclass correlation, and Cronbach's alpha were used for the analysis. Convergent validity was confirmed by good correlations between the CPWDQ and: clinical activity (r = 0.59, P < 0.01), the Short Inflammatory Bowel Disease Questionnaire, IBDQ-9, (r = 0.76, P < 0.001), Euroqol-5D (r = 0.53, P < 0.01), and overall work impairment (WPAI_CD) r = 0.66 (P < 0.01). Discriminant validity: CPWQ scores were higher in patients expected to have more severe disability, that is, in patients with active disease (n = 38) 32.3 ± 7.3 versus inactive (n = 70) 22.6 ± 5.9 (P < 0.001), in those requiring previous sick leave 30.7 ± 7.5 (n = 45) versus no sick leave 22.6 ± 6.6 (n = 63) (P < 0.01), and in those requiring hospitalization 32.2 ± 8.6 (n = 18) versus no hospitalization 24.7 ± 7.1 (n = 90) (P < 0.01). Internal consistency was also good (Cronbach's alpha = 0.89). Reproducibility: CPWDQ measures obtained 2 weeks apart showed an excellent intraclass correlation coefficient: 0.89 (95% CI: 0.83-0.93). The CPWDQ seems to be a valid, reliable tool for measuring subjective work disability in CD.Keywords
This publication has 34 references indexed in Scilit:
- Validation of the Spanish Work Productivity and Activity impairment questionnaire: Crohnʼs disease versionEuropean Journal of Gastroenterology & Hepatology, 2009
- The Direct and Indirect Cost Burden of Crohn's Disease and Ulcerative ColitisJournal of Occupational and Environmental Medicine, 2008
- Relationship between disease severity, quality of life and health‐care resource use in a cross‐section of Australian patients with Crohn's diseaseJournal of Gastroenterology and Hepatology, 2007
- Maintenance infliximab for Crohn's disease: the ACCENT I randomised trialThe Lancet, 2002
- Cost of Illness of Crohn??s DiseasePharmacoEconomics, 2002
- Disability from inflammatory bowel disease among employees in West Germany.Gut, 1989
- Prognosis and quality of life in patients with ulcerative colitis and Crohn's diseaseInternational Disability Studies, 1988
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986
- A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITYThe Lancet, 1980
- Coefficient Alpha and the Internal Structure of TestsPsychometrika, 1951